Ads
related to: Novartis Pharma AG- Quality by Design
A holistic, proactive approach
to drug development. Learn more.
- Biologics Development
Increase batch yield and reduce
processing time.
- Pharma Services Overview
Download our
free brochure.
- Pharma Trends Whitepaper
Get a CDMO's perspective on the
pharma trends you need to know.
- Early Development Paper
Learn how we can solve even your
your most complex challenges.
- In-house vs. Outsource?
Download this decision-making guide
for biologics development.
- Quality by Design
Search results
Biotech Stock Roundup: VYGR Gains From NVS Deal, AGIO Up on Study Data & More
Zacks via Yahoo Finance· 4 months agoIt was a busy week for the biotech sector, with numerous study readouts and other updates. Quite a...
Voyager (VYGR) Gains on Gene Therapy Deal With Novartis
Zacks via Yahoo Finance· 4 months agoVoyager (VYGR) enters into a capsid license agreement with Novartis for Huntington's disease and...
Voyager Therapeutics Inc (VYGR) Reports Q3 2023 Financial Results
GuruFocus.com via Yahoo Finance· 6 months agoVoyager Therapeutics Inc (NASDAQ:VYGR) reported a net loss of $25.9 million in Q3 2023, compared to...
Biotech company announces new leader
The High Point Enterprise, N.C. via Yahoo News· 2 years agoJul. 29—HIGH POINT — High Point pharmaceutical company vTv Therapeutics this week announced that Paul Sekhri will lead the company as president and CEO, effective Aug. 1. He will replace Rich ...
Ad
related to: Novartis Pharma AG
